Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IMPACT
NCT06770530Phase 4Recruiting
- Sponsor
- Rigshospitalet
- Start
- Jun 2024
- Primary completion
- Jun 2027
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of fluconazole in fungal infection, sponsored by Rigshospitalet. Started Jun 2024; status: recruiting.
02
Drugs
fluconazole
03
Conditions
fungal infection
Beyond the preview
Go deeper on NCT06770530.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06770530.